Hao Cui

1.9k total citations
84 papers, 1.3k citations indexed

About

Hao Cui is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Hao Cui has authored 84 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 28 papers in Epidemiology and 18 papers in Molecular Biology. Recurrent topics in Hao Cui's work include Cardiomyopathy and Myosin Studies (32 papers), Cardiovascular Function and Risk Factors (17 papers) and Cardiovascular Effects of Exercise (14 papers). Hao Cui is often cited by papers focused on Cardiomyopathy and Myosin Studies (32 papers), Cardiovascular Function and Risk Factors (17 papers) and Cardiovascular Effects of Exercise (14 papers). Hao Cui collaborates with scholars based in China, United States and Australia. Hao Cui's co-authors include Hartzell V. Schaff, Rick A. Nishimura, Steve R. Ommen, Joseph A. Dearani, Changsheng Zhu, Brian D. Lahr, Jeffrey B. Geske, Jianhua Lv, Huaijin Guan and Jialiang Zhao and has published in prestigious journals such as Journal of the American College of Cardiology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Hao Cui

77 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Cui China 20 437 345 293 283 208 84 1.3k
Andrea Facskó Hungary 19 116 0.3× 131 0.4× 402 1.4× 343 1.2× 354 1.7× 70 1.1k
Grzegorz Osmenda Poland 14 289 0.7× 111 0.3× 33 0.1× 210 0.7× 54 0.3× 21 1.1k
Xuan Yang China 18 44 0.1× 160 0.5× 164 0.6× 225 0.8× 123 0.6× 47 769
Naijin Zhang China 22 200 0.5× 233 0.7× 15 0.1× 730 2.6× 27 0.1× 71 1.3k
Young Joo Kim South Korea 21 183 0.4× 71 0.2× 24 0.1× 598 2.1× 93 0.4× 82 1.3k
Hongyu Kuang China 15 32 0.1× 148 0.4× 98 0.3× 277 1.0× 30 0.1× 39 720
Göran Bondjers Sweden 22 385 0.9× 232 0.7× 11 0.0× 698 2.5× 39 0.2× 42 2.0k
Yiting Liu China 19 32 0.1× 159 0.5× 48 0.2× 331 1.2× 45 0.2× 67 973
Mehmet Güven Türkiye 20 36 0.1× 93 0.3× 97 0.3× 431 1.5× 59 0.3× 71 1.0k

Countries citing papers authored by Hao Cui

Since Specialization
Citations

This map shows the geographic impact of Hao Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Cui more than expected).

Fields of papers citing papers by Hao Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Cui. The network helps show where Hao Cui may publish in the future.

Co-authorship network of co-authors of Hao Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Cui. A scholar is included among the top collaborators of Hao Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Cui. Hao Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Lushan, Hao Cui, Xiaobin Li, et al.. (2025). Metabolomic characterization of frailty identifies subtype-specific management strategies. npj Digital Medicine. 8(1). 746–746.
2.
3.
Peng, Xinyi, et al.. (2025). The engineered bone marrow mesenchymal stem cell-derived exosome: A new strategy for the treatment of inflammatory diseases. International Immunopharmacology. 162. 115136–115136.
4.
Yang, Jinfeng, Hui Qiu, Zhian Chen, et al.. (2024). Macrophage biomimetic intelligent hollow MnO2 nanoparticle for synergistic sonodynamic-immunotherapy of glioblastoma by crossing blood brain barrier. Materials & Design. 248. 113483–113483. 1 indexed citations
5.
Jia, Hao, Hao Cui, Ningning Zhang, et al.. (2024). Abnormal circadian rhythms exacerbate dilated cardiomyopathy by reducing the ventricular mechanical strength. Cardiovascular Research. 120(17). 2261–2277. 1 indexed citations
6.
Zhu, Changsheng, Hao Cui, Zining Wu, et al.. (2024). Clinical Outcomes of Concomitant Coronary Artery Bypass Grafting During Ventricular Septal Myectomy. Journal of the American Heart Association. 13(20). e036565–e036565. 1 indexed citations
7.
Schaff, Hartzell V., Hao Cui, Joseph A. Dearani, et al.. (2024). Outcomes of surgical septal myectomy for obstructive hypertrophic cardiomyopathy after previous septal reduction therapy. Journal of Thoracic and Cardiovascular Surgery. 169(5). 1483–1490.e1. 1 indexed citations
8.
Wang, Shengwei, et al.. (2024). Effect of type 2 diabetes on cardiac arrhythmias in patients with obstructive hypertrophic cardiomyopathy. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 18(3). 102992–102992. 2 indexed citations
9.
Yu, Jianbo, Jinwei Zhang, Shengwei Wang, et al.. (2023). Prevalence of Coronary Artery Disease in Patients Undergoing Valvular Heart Surgery. The Heart Surgery Forum. 26(2). E141–E147. 2 indexed citations
10.
Cui, Hao, Hartzell V. Schaff, Virend K. Somers, et al.. (2021). Sleep Disordered Breathing and Mortality in Patients With Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myectomy. Mayo Clinic Proceedings. 96(9). 2323–2331. 2 indexed citations
11.
Tang, Bing, et al.. (2020). Changes in left atrial function, left ventricle remodeling, and fibrosis after septal myectomy for obstructive hypertrophic cardiomyopathy. Journal of Thoracic and Cardiovascular Surgery. 163(5). 1828–1834.e4. 18 indexed citations
12.
Wang, Shengwei, Hao Cui, Changpeng Song, et al.. (2020). Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy. Cardiovascular Diabetology. 19(1). 64–64. 8 indexed citations
13.
14.
Wang, Shengwei, Hao Cui, Bing Tang, et al.. (2019). Mid‐term outcomes of simultaneous coronary artery bypass graft surgery and septal myectomy in patients with hypertrophic obstructive cardiomyopathy: A case‐controlled study. Journal of Cardiac Surgery. 34(3). 103–109. 5 indexed citations
15.
Wang, Shengwei, Hao Cui, Liukun Meng, et al.. (2019). Effect of Septal Myectomy on Obstructive Sleep Apnoea Syndrome in Patients With Hypertrophic Obstructive Cardiomyopathy. Heart Lung and Circulation. 29(9). 1366–1374. 4 indexed citations
16.
Cui, Hao, Hartzell V. Schaff, Martin Abel, et al.. (2019). Left ventricular ejection hemodynamics before and after relief of outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy and valvular aortic stenosis. Journal of Thoracic and Cardiovascular Surgery. 159(3). 844–852.e1. 15 indexed citations
17.
Tan, Fengbo, Xiaojin Feng, Jiawei Ren, et al.. (2018). [Tea consumption and the risk of lung cancer in Chinese males: a prospective cohort study].. PubMed. 52(5). 511–516. 1 indexed citations
18.
Wang, Shengwei, Hao Cui, Changpeng Song, et al.. (2018). Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy. Heart Rhythm. 16(5). 694–701. 21 indexed citations
19.
Zhao, Jialiang, Leon B. Ellwein, Hao Cui, et al.. (2010). Prevalence and Outcomes of Cataract Surgery in Rural China. Ophthalmology. 117(11). 2120–2128. 62 indexed citations
20.
Zhao, Jialiang, Leon B. Ellwein, Hao Cui, et al.. (2010). Prevalence of Vision Impairment in Older Adults in Rural China. Ophthalmology. 117(3). 409–416.e1. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Facskó Breakdown of academic impact, for papers by Grzegorz Osmenda Breakdown of academic impact, for papers by Xuan Yang Breakdown of academic impact, for papers by Naijin Zhang Breakdown of academic impact, for papers by Young Joo Kim Breakdown of academic impact, for papers by Hongyu Kuang Breakdown of academic impact, for papers by Göran Bondjers Breakdown of academic impact, for papers by Yiting Liu Breakdown of academic impact, for papers by Mehmet Güven
Rankless by CCL
2026